600488 津藥藥業
按盤價 
5.620 -0.080 (-1.404%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.425 | 2.317 | 4.440 | 3.950 | 1.187 |
| 總資產報酬率 ROA (%) | 0.750 | 1.232 | 2.254 | 1.830 | 0.545 |
| 投入資產回報率 ROIC (%) | 1.098 | 1.820 | 3.370 | 2.653 | 0.762 | 邊際利潤分析 |
| 銷售毛利率 (%) | 41.466 | 40.917 | 45.445 | 46.425 | 49.073 |
| 營業利潤率 (%) | 5.123 | 6.525 | 7.015 | 4.478 | 1.903 |
| 息稅前利潤/營業總收入 (%) | 6.355 | 4.718 | 7.292 | 4.902 | 1.132 |
| 淨利潤/營業總收入 (%) | 3.915 | 4.197 | 6.476 | 4.300 | 0.500 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 176.136 | 208.868 | 122.907 | 114.509 | 1,621.443 |
| 價值變動淨收益/利潤總額(%) | -0.128 | -0.654 | -4.014 | -0.669 | -179.255 |
| 營業外收支淨額/利潤總額(%) | 0.091 | -55.397 | 0.423 | -0.694 | -460.919 | 償債能力分析 |
| 流動比率 (X) | 1.408 | 1.881 | 1.485 | 1.086 | 1.035 |
| 速動比率 (X) | 1.038 | 1.381 | 0.949 | 0.713 | 0.528 |
| 資產負債率 (%) | 33.134 | 32.379 | 31.806 | 38.896 | 43.557 |
| 帶息債務/全部投入資本 (%) | 18.297 | 18.927 | 15.280 | 23.921 | 33.617 |
| 股東權益/帶息債務 (%) | 421.388 | 406.559 | 524.793 | 300.551 | 187.495 |
| 股東權益/負債合計 (%) | 158.723 | 162.704 | 168.688 | 123.622 | 102.611 |
| 利息保障倍數 (X) | 5.178 | 9.093 | 29.552 | 10.775 | 1.428 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 77.452 | 51.348 | 40.374 | 36.739 | 41.144 |
| 存貨周轉天數 (天) | 137.717 | 129.463 | 141.355 | 167.252 | 204.385 |
| 備註： | 即時報價更新時間為 28/08/2026 10:41 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
